Simplex Trading
ABEO icon

Simplex Trading’s Abeona Therapeutics ABEO Stock Holding History

Simplex Trading’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$270K Buy
60,300
+56,700
+1,575% +$283K ﹤0.01% 3936
2025
Q4 		$19K Sell
3,600
-5,200
-59% -$26.2K ﹤0.01% 6521
2025
Q3 		$46K Sell
8,800
-15,500
-64% -$98.3K ﹤0.01% 6531
2025
Q2 		$138K Buy
24,300
+5,400
+29% +$30.7K ﹤0.01% 4900
2025
Q1 		$89K Buy
18,900
+7,500
+66% +$40.8K ﹤0.01% 5170
2024
Q4 		$63K Sell
11,400
-16,200
-59% -$99.7K ﹤0.01% 5621
2024
Q3 		$174K Buy
27,600
+1,600
+6% +$8.35K ﹤0.01% 4654
2024
Q2 		$110K Buy
26,000
+2,300
+10% +$11.7K ﹤0.01% 5280
2024
Q1 		$171K Buy
23,700
+15,400
+186% +$97.6K ﹤0.01% 5023
2023
Q4 		$41K Buy
+8,300
New +$36.5K ﹤0.01% 6266
2022
Q2 		– Sell
-160
Closed -$1K – 9805
2022
Q1 		$1K Sell
160
-96
-38% -$659 ﹤0.01% 10015
2021
Q4 		$2K Sell
256
-880
-77% -$16.2K ﹤0.01% 9942
2021
Q3 		$44K Hold
1,136
– – ﹤0.01% 7648
2021
Q2 		$44K Buy
+1,136
New +$46.3K ﹤0.01% 7790
2021
Q1 		– Sell
-14
Closed -$56K – 8627
2020
Q4 		$56K Buy
14
+11
+367% +$375 ﹤0.01% 6047
2020
Q3 		$8K Sell
3
-5
-63% -$315 ﹤0.01% 6876
2020
Q2 		$56K Buy
8
+6
+300% +$415 ﹤0.01% 5386
2020
Q1 		$11K Sell
2
-4
-67% -$267 ﹤0.01% 6391
2019
Q4 		$46K Sell
6
-4
-40% -$282 ﹤0.01% 5266
2019
Q3 		$56K Buy
10
+2
+25% +$150 ﹤0.01% 4903
2019
Q2 		$97K Sell
8
-18
-69% -$3.02K ﹤0.01% 4217
2019
Q1 		$485K Buy
26
+1
+4% +$179 ﹤0.01% 2693
2018
Q4 		$450K Buy
25
+14
+127% +$3.05K ﹤0.01% 2329
2018
Q3 		$349K Sell
11
-3
-21% -$1.06K ﹤0.01% 2999
2018
Q2 		$544K Hold
14
– – ﹤0.01% 2379
2018
Q1 		$44K Sell
14
-5
-26% -$1.86K ﹤0.01% 2559
2017
Q4 		$52K Buy
19
+2
+12% +$827 ﹤0.01% 2405
2017
Q3 		$305K Buy
17
+15
+750% +$4.03K 0.01% 946
2017
Q2 		$3K Buy
2
+1
+100% +$136 ﹤0.01% 4899
2017
Q1 		$1K Sell
1
-5
-83% -$645 ﹤0.01% 5509
2016
Q4 		$7K Buy
+6
New +$939 ﹤0.01% 4014
2016
Q3 		– Sell
-1
Closed -$7K – 5694
2016
Q2 		$7K Buy
+1
New +$68 ﹤0.01% 3893

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's ABEO Position: Q1 2026 in Review

Simplex Trading reduced its Abeona Therapeutics (ABEO) stake by 68% in Q1 2026, selling an estimated $336K and leaving 31,096 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #4715.

Simplex Trading first reported a position in ABEO in Q2 2015 and has held it in 27 quarters since. The position peaked at $518K in Q4 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Simplex Trading held 31,096 shares of Abeona Therapeutics worth $139K as of Q1 2026.
  • Simplex Trading sold 67,142 Abeona Therapeutics shares in Q1 2026, an estimated $336K.
  • Abeona Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4715 holding.
  • Simplex Trading first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 27 quarters since.
  • Simplex Trading's Abeona Therapeutics position peaked at $518K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.